 Scott Demarest
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 39 | 2025 | 133 | 11.610 |
Why?
| | Epileptic Syndromes | 35 | 2025 | 92 | 10.120 |
Why?
| | Epilepsy | 21 | 2025 | 349 | 5.860 |
Why?
| | Vision Disorders | 8 | 2025 | 168 | 2.440 |
Why?
| | Precision Medicine | 6 | 2024 | 434 | 1.820 |
Why?
| | Neurodevelopmental Disorders | 5 | 2026 | 210 | 1.700 |
Why?
| | Seizures | 15 | 2025 | 442 | 1.450 |
Why?
| | Anticonvulsants | 9 | 2023 | 226 | 1.430 |
Why?
| | Genetic Testing | 5 | 2023 | 463 | 1.360 |
Why?
| | Developmental Disabilities | 4 | 2026 | 284 | 1.310 |
Why?
| | Psychometrics | 7 | 2024 | 739 | 1.240 |
Why?
| | Gene Editing | 2 | 2021 | 86 | 1.210 |
Why?
| | Pregnanolone | 3 | 2024 | 42 | 1.040 |
Why?
| | Child, Preschool | 28 | 2026 | 11512 | 0.990 |
Why?
| | Genetic Therapy | 3 | 2024 | 315 | 0.950 |
Why?
| | Child | 39 | 2026 | 22414 | 0.940 |
Why?
| | Infant | 23 | 2025 | 9843 | 0.880 |
Why?
| | Caregivers | 5 | 2025 | 943 | 0.880 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2023 | 6 | 0.840 |
Why?
| | Epilepsies, Myoclonic | 3 | 2020 | 57 | 0.840 |
Why?
| | Electroencephalography | 11 | 2025 | 524 | 0.760 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2022 | 38 | 0.730 |
Why?
| | Severity of Illness Index | 4 | 2025 | 2903 | 0.720 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 34 | 0.710 |
Why?
| | Long QT Syndrome | 1 | 2022 | 70 | 0.710 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.710 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 258 | 0.660 |
Why?
| | Adolescent | 23 | 2026 | 22130 | 0.630 |
Why?
| | Sleep Wake Disorders | 2 | 2024 | 308 | 0.600 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 192 | 0.600 |
Why?
| | Humans | 63 | 2026 | 141754 | 0.600 |
Why?
| | Quality of Life | 9 | 2025 | 3014 | 0.570 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.560 |
Why?
| | Symptom Assessment | 1 | 2019 | 130 | 0.550 |
Why?
| | Clinical Trials as Topic | 4 | 2024 | 1057 | 0.510 |
Why?
| | Parents | 5 | 2025 | 1440 | 0.480 |
Why?
| | Physicians | 1 | 2024 | 942 | 0.470 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 547 | 0.450 |
Why?
| | Male | 32 | 2026 | 70179 | 0.440 |
Why?
| | Communication | 4 | 2025 | 951 | 0.440 |
Why?
| | MELAS Syndrome | 1 | 2014 | 5 | 0.440 |
Why?
| | Genetic Predisposition to Disease | 1 | 2023 | 2375 | 0.430 |
Why?
| | Female | 32 | 2026 | 75943 | 0.420 |
Why?
| | Cohort Studies | 6 | 2025 | 5815 | 0.420 |
Why?
| | Phenotype | 8 | 2025 | 3177 | 0.410 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 5974 | 0.410 |
Why?
| | Genetic Association Studies | 3 | 2020 | 375 | 0.410 |
Why?
| | DNA, Mitochondrial | 1 | 2014 | 211 | 0.390 |
Why?
| | Movement Disorders | 3 | 2023 | 65 | 0.380 |
Why?
| | Double-Blind Method | 4 | 2024 | 1989 | 0.360 |
Why?
| | Reproducibility of Results | 9 | 2025 | 3356 | 0.360 |
Why?
| | Age of Onset | 3 | 2025 | 534 | 0.350 |
Why?
| | Adrenocorticotropic Hormone | 3 | 2023 | 148 | 0.350 |
Why?
| | Infant, Newborn | 5 | 2025 | 6289 | 0.320 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 19 | 0.310 |
Why?
| | Communication Disorders | 2 | 2025 | 14 | 0.290 |
Why?
| | Rett Syndrome | 3 | 2024 | 40 | 0.290 |
Why?
| | Young Adult | 11 | 2026 | 13749 | 0.280 |
Why?
| | Retrospective Studies | 7 | 2025 | 16374 | 0.260 |
Why?
| | Treatment Outcome | 7 | 2024 | 11181 | 0.260 |
Why?
| | Adult | 15 | 2026 | 39391 | 0.250 |
Why?
| | Mutation | 5 | 2021 | 4015 | 0.250 |
Why?
| | Catatonia | 1 | 2026 | 13 | 0.240 |
Why?
| | Brain | 2 | 2014 | 2868 | 0.230 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2024 | 34 | 0.220 |
Why?
| | Genetic Diseases, Inborn | 1 | 2024 | 47 | 0.220 |
Why?
| | Chromosome Disorders | 1 | 2024 | 43 | 0.220 |
Why?
| | 5' Untranslated Regions | 1 | 2024 | 59 | 0.220 |
Why?
| | Disability Evaluation | 1 | 2025 | 304 | 0.210 |
Why?
| | Psychotic Disorders | 1 | 2026 | 179 | 0.200 |
Why?
| | Status Epilepticus | 1 | 2023 | 54 | 0.200 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2023 | 131 | 0.190 |
Why?
| | Sex Factors | 2 | 2019 | 2063 | 0.190 |
Why?
| | Brain Diseases | 1 | 2023 | 149 | 0.190 |
Why?
| | Vigabatrin | 2 | 2023 | 19 | 0.190 |
Why?
| | Checklist | 1 | 2023 | 106 | 0.180 |
Why?
| | Child Behavior | 1 | 2024 | 251 | 0.180 |
Why?
| | Vagus Nerve Stimulation | 2 | 2019 | 29 | 0.180 |
Why?
| | Neurologists | 1 | 2021 | 22 | 0.180 |
Why?
| | Piperidines | 1 | 2023 | 218 | 0.170 |
Why?
| | Oligonucleotides, Antisense | 1 | 2021 | 112 | 0.170 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5697 | 0.170 |
Why?
| | Intellectual Disability | 1 | 2022 | 173 | 0.170 |
Why?
| | Infusions, Intraventricular | 1 | 2020 | 4 | 0.170 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2020 | 4 | 0.160 |
Why?
| | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2020 | 6 | 0.160 |
Why?
| | Aminopeptidases | 1 | 2020 | 22 | 0.160 |
Why?
| | Leukoencephalopathies | 1 | 2020 | 19 | 0.160 |
Why?
| | Infusion Pumps | 1 | 2020 | 34 | 0.160 |
Why?
| | Serine Proteases | 1 | 2020 | 19 | 0.160 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 1041 | 0.160 |
Why?
| | Hemiplegia | 1 | 2019 | 21 | 0.160 |
Why?
| | Electrocardiography | 1 | 2022 | 618 | 0.150 |
Why?
| | Dystonic Disorders | 1 | 2019 | 27 | 0.150 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 55 | 0.150 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 8 | 0.150 |
Why?
| | Speech Disorders | 1 | 2019 | 31 | 0.150 |
Why?
| | Spasm | 3 | 2023 | 21 | 0.150 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2019 | 32 | 0.150 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 21 | 0.150 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 34 | 0.150 |
Why?
| | Pyridines | 1 | 2023 | 557 | 0.150 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 41 | 0.150 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.150 |
Why?
| | Disease Management | 2 | 2024 | 633 | 0.140 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 210 | 0.140 |
Why?
| | Preexisting Condition Coverage | 1 | 2017 | 3 | 0.140 |
Why?
| | Cognition Disorders | 2 | 2019 | 518 | 0.140 |
Why?
| | Family Health | 1 | 2019 | 194 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 141 | 0.130 |
Why?
| | Prednisolone | 1 | 2017 | 69 | 0.130 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 217 | 0.130 |
Why?
| | Family | 1 | 2022 | 680 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1826 | 0.130 |
Why?
| | Delphi Technique | 1 | 2019 | 313 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 825 | 0.130 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1363 | 0.130 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 106 | 0.130 |
Why?
| | Genomics | 1 | 2021 | 815 | 0.120 |
Why?
| | Health Surveys | 1 | 2018 | 513 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 605 | 0.110 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2014 | 29 | 0.110 |
Why?
| | Patient Care Team | 1 | 2020 | 673 | 0.110 |
Why?
| | Nervous System Malformations | 1 | 2014 | 43 | 0.110 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5212 | 0.110 |
Why?
| | Point Mutation | 1 | 2014 | 237 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2800 | 0.100 |
Why?
| | Proteins | 1 | 2019 | 1015 | 0.100 |
Why?
| | Prospective Studies | 3 | 2022 | 7777 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1570 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3294 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1485 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4421 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 1100 | 0.080 |
Why?
| | Zebrafish | 2 | 2026 | 504 | 0.070 |
Why?
| | Research Design | 2 | 2024 | 1146 | 0.070 |
Why?
| | Qualitative Research | 2 | 2025 | 1547 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2019 | 737 | 0.060 |
Why?
| | Chromosome Deletion | 1 | 2024 | 118 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2024 | 183 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2023 | 29 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2023 | 33 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 212 | 0.050 |
Why?
| | Rare Diseases | 1 | 2024 | 112 | 0.050 |
Why?
| | Animals | 3 | 2026 | 37749 | 0.050 |
Why?
| | Exons | 1 | 2024 | 353 | 0.050 |
Why?
| | Motor Skills | 1 | 2024 | 103 | 0.050 |
Why?
| | Suggestion | 1 | 2022 | 2 | 0.050 |
Why?
| | Munc18 Proteins | 1 | 2022 | 24 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3737 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2022 | 160 | 0.040 |
Why?
| | Patient Acuity | 1 | 2021 | 47 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2023 | 223 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 437 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2022 | 121 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2022 | 377 | 0.040 |
Why?
| | Proteostasis Deficiencies | 1 | 2019 | 5 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 501 | 0.040 |
Why?
| | Vitamin B 6 Deficiency | 1 | 2019 | 6 | 0.040 |
Why?
| | Vitamin B 6 | 1 | 2019 | 11 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2019 | 60 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2019 | 24 | 0.040 |
Why?
| | Pyridoxine | 1 | 2019 | 36 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 193 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2019 | 36 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2019 | 70 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2020 | 340 | 0.040 |
Why?
| | White Matter | 1 | 2020 | 148 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 547 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 582 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 448 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2021 | 854 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2799 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 232 | 0.030 |
Why?
| | Emotions | 1 | 2022 | 579 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 207 | 0.030 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 419 | 0.030 |
Why?
| | Advisory Committees | 1 | 2018 | 220 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 891 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 941 | 0.030 |
Why?
| | Down Syndrome | 1 | 2022 | 506 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1866 | 0.030 |
Why?
| | United States | 2 | 2024 | 15310 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 481 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1604 | 0.030 |
Why?
| | Middle Aged | 2 | 2025 | 34647 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1977 | 0.020 |
Why?
| | Logistic Models | 1 | 2014 | 2092 | 0.020 |
Why?
| | Aged | 1 | 2022 | 24746 | 0.010 |
Why?
|
|
Demarest's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|